23andMe
human genetics has the potential to double the probability of success in drug development wrong wrong outcomes and translational mitigate | 23andMe
Company
Deck Type
Sector
Industry
Deck date
January 2022
Slide
18 of 78
Related slides by other companies
Exscientia
Investor Day
January 2024
ways we can improve probability of success | Exscientia
P3 Health Partners
Investor Conference
September 2023
the economic model works improving costs and outcomes contracts with high quality contract with to patients are supported | P3 Health Partners
ATAI
Investor Presentation
June 2020
drug discovery enabling technologies our are designed to drive efficient and improved treatment outcomes introspect | ATAI
Navidea Biopharmaceuticals
Investor Presentation
May 2022
why focus on rheumatoid arthritis | Navidea Biopharmaceuticals
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io